CellNostix™ is Ridgetop Group’s next-generation Battery Diagnostic and Prognostic System (BDPS), purpose-built to bridge empirical battery testing with physics-informed predictive modeling and prognostics. Developed through U.S. Department of Energy–supported research and refined using Ridgetop’s rigorous Systems Engineering Process, CellNostix enables battery researchers to move beyond raw test data toward explainable insights into degradation mechanisms, performance limits, and remaining useful life.

At its core, CellNostix™ integrates hardware-in-the-loop (HIL) testing, multi-physics simulation, and model-informed prognostic reasoning within a single, unified platform. Users can execute real cycle-life experiments, synchronize high-resolution telemetry with validated battery models, and quantitatively compare measured behavior against physics-based predictions. This closed-loop workflow supports rapid hypothesis testing, accelerated model validation, and confident, data-driven decision making across the battery R&D lifecycle.

Designed in accordance with the IEEE 1856-2017 Standard Framework for Prognostics and Health Management of Electronic Systems, CellNostix™ provides a scalable foundation for laboratory research, manufacturing validation, and advanced battery health assessment. Whether evaluating new chemistries, optimizing duty cycles, or forecasting end-of-life behavior, CellNostix delivers a unified environment for understanding why batteries degrade—and how to act on that insight.